Indegene Private Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Indegene Private Limited - overview
Established
1998
Location
Bangalore, Karnataka, India
Primary Industry
Healthcare IT
About
Established in 1998, Indegene Private Limited, based in Bengaluru, India, is a digital-first life sciences commercialization company focused on delivering innovative solutions that enhance operational effectiveness in the biopharmaceutical and medical device sectors. Indegene Private Limited specializes in life sciences commercialization, providing comprehensive solutions for biopharmaceutical and medical device industries. Founded in 1998 in Bengaluru, India, by Anand Kiran, Dang Tran, Dennis van Rooij, and Sanjay Parikh, the company has undergone strategic transformations to adapt to market needs. It has raised a total of INR 5480.
00 mn across multiple funding rounds, with the most recent funding of INR 5480. 00 mn from a BUYOUT round completed on February 2, 2021, led by investors including Abu Dhabi Investment Authority and Fidelity Investments. Indegene offers a range of services designed for the biopharmaceutical and medical device industries. Their core offerings include Enterprise Commercial Solutions for improved customer experience, Enterprise Medical Solutions focusing on regulatory compliance, and Enterprise Clinical Solutions for managing Real-World Data.
The company also leverages Gen AI-powered tools to facilitate data-driven decision-making and enhance customer engagement, catering to a broad client base including 19 of the top 20 global biopharmaceutical companies across North America, Europe, and Asia. In the most recent year, 2023, Indegene reported a revenue of INR 287,341,455 and an EBITDA of INR 56,591,414. The company primarily generates revenue through B2B partnerships and subscription models, providing essential services that support the commercialization strategies of pharmaceutical and biotech firms. Indegene plans to leverage its recent funding of INR 5480.
00 mn to accelerate its M&A and global expansion initiatives. The company is focused on launching new products aimed at enhancing its service offerings, while also targeting expansion into new geographic regions, including further penetration into emerging markets in Asia and Europe by 2025.
Current Investors
Carlyle Group, Brighton Park Capital, Capital Group Private Markets
Primary Industry
Healthcare IT
Sub Industries
eMarketing/Digital Marketing, Healthcare, Healthcare IT, Analytics & Performance Software, Medical Software, Sales & Marketing Software
Website
www.indegene.com
Verticals
Cloud Computing, HealthTech
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Indegene Private Limited - timeline of key events
Indegene Private Limited - financials
| Fiscal Year Ended | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | 892,171,198 | 1,090,038,423 | 3,437,533,384 | 4,720,601,843 | 4,751,152,605 | 5,532,837,496 | 6,507,862,971 | - | - | - |
| % Revenue Growth (YoY) | - | - | 22.2% | 215.4% | 37.3% | 0.6% | 16.5% | 17.6% | - | - | - |
| EBITDA (USD) | 108,728,000 | 122,470,125 | 141,343,019 | 557,962,699 | 708,440,859 | 305,460,221 | 482,861,174 | 862,556,059 | - | - | - |
| Operating Income (USD) | 85,529,000 | 91,916,957 | 115,117,558 | 406,092,276 | 517,288,934 | 184,639,274 | 316,813,067 | 668,963,751 | - | - | - |
| Operating Margin | - | 10.3% | 10.6% | 11.8% | 11.0% | 3.9% | 5.7% | 10.3% | - | - | - |
| % EBITDA Margin | - | 13.7% | 13.0% | 16.2% | 15.0% | 6.4% | 8.7% | 13.3% | - | - | - |
| NET Income (USD) | 66,002,000 | 76,732,237 | 114,973,018 | 354,311,620 | 390,782,169 | 40,092,841 | 140,910,809 | 308,759,040 | - | - | - |
| % Net Margin | - | 8.6% | 10.5% | 10.3% | 8.3% | 0.8% | 2.5% | 4.7% | - | - | - |
Indegene Private Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Warn and Co Limited | - | ||||||||
| IPO | Completed | Indegene Private Limited | - | ||||||||
| Buyout | Completed | Indegene Private Limited | - | ||||||||
| Add-on | Completed | Trilogy Writing & Consulting GmbH | - | ||||||||
| Unspecified Exit | Completed | Indegene Private Limited | - |
Displaying 1 - 5 of 8
Indegene Private Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.